Filing Details

Accession Number:
0001137439-25-000157
Form Type:
13G Filing
Publication Date:
2025-03-02 19:00:00
Filed By:
Dauntless Investment Group, LLC
Company:
Aeon Biopharma Inc.
Filing Date:
2025-03-03
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Dauntless Investment Group, LLC 0 108,224 9.7%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Single Family Office/Passive Investor


SCHEDULE 13G


 
Dauntless Investment Group, LLC
 
Signature:/s/Matthew Okkerse
Name/Title:CFO
Date:02/27/2025